Close

Intercept Pharma (ICPT) Announces NEJM Published Results of Phase 3 POISE Trial of Ocaliva for PBC

Go back to Intercept Pharma (ICPT) Announces NEJM Published Results of Phase 3 POISE Trial of Ocaliva for PBC